Medications & Treatments

Landmark ADMIRAL Study Validates CareDx’s AlloSure ® Kidney for Routine Organ Transplant Surveillance

Landmark ADMIRAL Study Validates CareDx’s AlloSure ® Kidney for Routine Organ Transplant Surveillance

Dr. Matthew Weir, Attending Physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital discusses the large ADMIRAL trial that confirms AlloSure ® Kidney as an effective non-invasive diagnostic that can be used routinely in the surveillance setting to assess organ health. It is an improvement over the standard-of-care serum creatinine and has become an invaluable tool for nephrologists working to preserve donated kidneys, keeping patients healthy and off dialysis.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Hypertension. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Hypertension and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Hypertension?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Matthew R. Weir, M.D. is attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore.   He is also Professor of Medicine at the University of Maryland School of Medicine.  Dr. Weir’s primary research interests include the use of antihypertensive therapy for the treatment of diabetic nephropathy, hypertensive renal injury in African Americans, cardiovascular disease in patients with chronic kidney disease, and mineralocorticoid receptor antagonism to treat atherosclerosis. He has written more than 600 manuscripts and book chapters about these topics.   He has edited 8 books on topics in nephrology, transplantation, and hypertension. He has presented at numerous international scientific association meetings, hospitals, and medical schools.  Dr. Weir currently reviews manuscripts for more than 30 major medical journals, including the American Society of Nephrology, and Archives of Internal Medicine.   He is on the editorial board of 18 journals and is Section Editor of Current Hypertension Reports and Current Opinion in Hypertension and Nephrology, and Associate Editor of Clinical Nephrology and the American Journal of Nephrology.   He has 5 active NIH supported grants: three from NIDDK, and two from NHLBI.   In addition, he is a member of numerous associations, including the American Society of Nephrology, the National Kidney Foundation, the American Heart Association, and the American Society of Transplantation.  Dr. Weir received his medical degree from the University of Virginia, Charlottesville.   He completed his internship and residency programs in medicine at the Waterbury and Yale-New Haven Hospitals in Connecticut, and completed his nephrology training at the Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts.   He then moved to then to the University of Maryland where he has been a full time faculty member since 1983.

Last updated: February 17, 2022

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.